U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H11NO2
Molecular Weight 165.1891
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ETHENZAMIDE

SMILES

CCOC1=C(C=CC=C1)C(N)=O

InChI

InChIKey=SBNKFTQSBPKMBZ-UHFFFAOYSA-N
InChI=1S/C9H11NO2/c1-2-12-8-6-4-3-5-7(8)9(10)11/h3-6H,2H2,1H3,(H2,10,11)

HIDE SMILES / InChI

Molecular Formula C9H11NO2
Molecular Weight 165.1891
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Ethenzamide is an anti-inflammatory agent that was used for the treatment of common cold in Japan (in combinations with other NSAIDs).

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
NARON ACE

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Preparation and clinical application of 2% diflunisal oral ointment for painful lesions of the oral mucosa.
2001 Nov
Preparation of solid dispersion for ethenzamide-carbopol and theophylline-carbopol systems using a twin screw extruder.
2002 Jun
Cutaneous drug reaction case reports: from the world literature.
2003
Assessment of tableting properties using infinitesimal quantities of powdered medicine.
2003 Sep 16
Continuous grinding kinetics of ethenzamide particles by fluidized-bed jet-milling.
2006 Mar
Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose.
2006 Mar 9
Dissolution characteristics of cylindrical particles and tablets.
2006 Mar 9
One-step preparation of drug-containing microparticles to enhance the dissolution and absorption of poorly water-soluble drugs using a 4-fluid nozzle spray drier.
2007 Jul 31
Evaluation of pharmaceuticals and personal care products as water-soluble molecular markers of sewage.
2008 Sep 1
Theophylline-gentisic acid (1/1).
2009 Aug 8
Distribution of ethenzamide and other ingredients on granule surfaces studied by Raman microspectroscopy and mapping.
2009 May
Development, characterization and solubility study of solid dispersions of azithromycin dihydrate by solvent evaporation method.
2010 Apr
Patents

Sample Use Guides

2 pills containing 84 mg of ethenzamide 3 times a day.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 04:51:05 GMT 2023
Edited
by admin
on Sat Dec 16 04:51:05 GMT 2023
Record UNII
L929ZCK4BF
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ETHENZAMIDE
INN   MART.   MI   WHO-DD  
INN  
Official Name English
Ethenzamide [WHO-DD]
Common Name English
ETHENZAMIDE [MI]
Common Name English
ETHENZAMIDE [JAN]
Common Name English
O-ETHOXYBENZAMIDE
Common Name English
ETENZAMIDE
Common Name English
NSC-28787
Code English
ethenzamide [INN]
Common Name English
ETHOXYBENZAMIDE
Systematic Name English
ETHENZAMIDE [MART.]
Common Name English
J3.352I
Code English
Classification Tree Code System Code
WHO-ATC N02BA77
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
NCI_THESAURUS C257
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
WHO-VATC QN02BA57
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
WHO-VATC QN02BA07
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
WHO-ATC N02BA07
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
WHO-ATC N02BA57
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
Code System Code Type Description
ECHA (EC/EINECS)
213-346-4
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
SMS_ID
100000082616
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
ChEMBL
CHEMBL1483877
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
EVMPD
SUB07274MIG
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
FDA UNII
L929ZCK4BF
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
EPA CompTox
DTXSID4020581
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
CAS
938-73-8
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
DRUG BANK
DB13544
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
MESH
C018935
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
PUBCHEM
3282
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
DRUG CENTRAL
1080
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
WIKIPEDIA
ETHENZAMIDE
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
NCI_THESAURUS
C87323
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
RXCUI
24468
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY RxNorm
INN
903
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
MERCK INDEX
m5056
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY Merck Index
NSC
28787
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
DAILYMED
L929ZCK4BF
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY